Tag Archives: CVC and Apollo partnership strengthens Syntegon’s expansion plans and leadership in pharma biotech and food technology markets

CVC retains majority stake in Syntegon as Apollo joins as strategic minority investor to support next phase of global growth

(IN BRIEF) CVC Capital Partners has agreed to sell a 37% minority stake in Syntegon to Apollo-managed funds while retaining majority ownership, marking the start of a new growth phase for the company. Since CVC’s investment, Syntegon has achieved strong … Read the full press release